Elpidoforos S. Soteriades, M.D., Jane C. Evans, D.Sc., Martin G. Larson, Sc.D., Ming Hui Chen, M.D., Leway Chen, M.D., Emelia J. Benjamin, M.D., and Daniel Levy, M.D.
Background Little is known about the epidemiology and prognosisof syncope in the general population.
Methods We evaluated the incidence, specific causes, and prognosisof syncope among women and men participating in the FraminghamHeart Study from 1971 to 1998.
Results Of 7814 study participants followed for an average of17 years, 822 reported syncope. The incidence of a first reportof syncope was 6.2 per 1000 person-years. The most frequentlyidentified causes were vasovagal (21.2 percent), cardiac (9.5percent), and orthostatic (9.4 percent); for 36.6 percent thecause was unknown. The multivariable-adjusted hazard ratiosamong participants with syncope from any cause, as comparedwith those who did not have syncope, were 1.31 (95 percent confidenceinterval, 1.14 to 1.51) for death from any cause, 1.27 (95 percentconfidence interval, 0.99 to 1.64) for myocardial infarctionor death from coronary heart disease, and 1.06 (95 percent confidenceinterval, 0.77 to 1.45) for fatal or nonfatal stroke. The correspondinghazard ratios among participants with cardiac syncope were 2.01(95 percent confidence interval, 1.48 to 2.73), 2.66 (95 percentconfidence interval, 1.69 to 4.19), and 2.01 (95 percent confidenceinterval, 1.06 to 3.80). Participants with syncope of unknowncause and those with neurologic syncope had increased risksof death from any cause, with multivariable-adjusted hazardratios of 1.32 (95 percent confidence interval, 1.09 to 1.60)and 1.54 (95 percent confidence interval, 1.12 to 2.12), respectively.There was no increased risk of cardiovascular morbidity or mortalityassociated with vasovagal (including orthostatic and medication-related)syncope.
Conclusions Persons with cardiac syncope are at increased riskfor death from any cause and cardiovascular events, and personswith syncope of unknown cause are at increased risk for deathfrom any cause. Vasovagal syncope appears to have a benign prognosis.
Syncope, defined as a sudden loss of consciousness associatedwith the inability to maintain postural tone, followed by spontaneousrecovery, is relatively common. However, the epidemiology andprognosis of syncope in the community have not been well described.Data are limited on the cumulative incidence1,2 and lifetimeprevalence3,4,5,6,7 of syncope.
Although syncope has many possible causes, several studies haveused three categories of cause — cardiac, noncardiac,and unknown — to examine the prognosis of syncope prospectively.8Previous studies of syncope were conducted in emergency departments,9,10,11,12in general hospitals,13,14,15,16,17 and among highly selectedsubgroups of patients with syncope of unknown cause.18,19,20,21,22,23,24,25,26,27Little is known about the prognosis of syncope due to specificcauses in the general population. We conducted a study to evaluatethe incidence and prognosis of syncope due to specific causesamong participants in the Framingham Heart Study.
Methods
Study Sample
The study sample consisted of participants in the original FraminghamHeart Study and in the Framingham Offspring Study who underwentroutine clinical examinations between 1971 and 1998. The detailsof the study design and selection criteria have been describedelsewhere.28,29 We examined all reports of syncope in studyparticipants undergoing a qualifying clinical examination. Syncopereports were coded as "yes," "no," or "maybe." A committee ofphysicians reviewed all episodes coded as "maybe." Possibleepisodes of syncope were coded as definite only if the participant'schart contained additional medical information confirming asyncopal event that had not been available at the time of theinitial clinical evaluation. We excluded 120 equivocal reportsof syncope, 101 reports of syncope from participants who hadnot had an examination within four years before the index report(to minimize possible recall bias), 47 reports of syncope dueto head trauma, and 7 reports of syncope with incomplete records.All participants undergoing examination in the Framingham HeartStudy provided written informed consent; the content and proceduresof the examinations were reviewed and approved by the institutionalreview board of Boston Medical Center.
Incidence
The overall incidence rate of syncope and the incidence ratesfor syncope with specific causes were calculated by dividingthe number of participants with syncope by the total numberof person-years of follow-up in each subgroup. For the calculationof incidence rates in different age groups, we categorized participantsaccording to their age halfway between the time of the clinicalexamination preceding the report of syncope and the time ofthe index examination for syncope. We calculated the cumulativeincidence by assuming a constant incidence over time, usingthe following formula:
cumulative incidence = 1 – e–It,
where e is the natural logarithm constant (2.718), I denotesthe incidence rate, and t denotes the duration of follow-up.
Causes of Syncope
The cause of syncope was assigned according to a clinical diagnosismade by two physicians (an internist and a cardiologist) onthe basis of documentation provided by the examining FraminghamHeart Study physician and information obtained during routineclinic visits from the medical history, physical examination,and electrocardiographic examination. In addition, the physiciansreviewed all available hospital and outpatient medical recordspertaining to each instance of syncope. Generally, the dischargediagnosis was used for participants evaluated at an outsidehospital, as long as this diagnosis was supported by associatedrecords. For other participants, the diagnosis of the examiningFramingham Heart Study physician was used. If a cardiovascularcause was suspected, a second evaluation was performed by anotherFramingham Heart Study physician. If these evaluations did notagree, the physician reviewers evaluated available data to assigna cause.
Reports of syncope were classified into eight categories accordingto cause: cardiac cause (including ischemia and arrhythmias),unknown cause, stroke or transient ischemic attack, seizuredisorder, vasovagal cause, orthostatic cause, medication, andother, infrequent causes (including cough syncope, micturitionsyncope, and situational syncope). These eight categories werereduced to four etiologic categories for the outcome analysis:cardiac cause, unknown cause, neurologic cause (including syncopedue to stroke, transient ischemic attack, and seizure), andvasovagal or other cause (including vasovagal syncope, orthostaticsyncope, medication-induced syncope, and syncope due to otheridentified causes). Secondary analyses were also performed afterwe excluded syncope due to seizure from the category of neurologicsyncope. When a participant did not seek medical attention forsyncope and the history, physical examination, and electrocardiographicfindings were not indicative of any of the specific causes,the cause was classified as unknown. The physicians who confirmedthe diagnoses of syncope and assigned the causes were unawareof subsequent outcomes.
Recurrence of Syncope
The first episode of syncope reported by a participant duringa clinical examination was treated as the first syncopal event.If more than one syncopal event was reported between clinicvisits, we counted only one episode of syncope. Episodes reportedat subsequent clinical examinations were considered recurrencesof syncope.
End Points
The participants in the follow-up sample were followed for upto 25 years. A prospective cohort design was used to study threeoutcomes in relation to syncope: death from any cause, myocardialinfarction or death from coronary heart disease (which includedboth sudden and nonsudden death from coronary heart disease),and fatal or nonfatal stroke. All outcome events were reviewedwith the use of all pertinent available medical records andadjudicated on the basis of previously published criteria.30Data from 95 participants who reported syncope during theirlast index examination were excluded from the outcome analysis,because no follow-up data were available for them. For eachparticipant with syncope, we randomly selected two participantswithout syncope who underwent clinical examination at the FraminghamHeart Study clinic during the same examination cycle, matchedaccording to age and sex.
Statistical Analysis
All statistical analyses were performed with SAS software (version6.12).31 The age-, sex-, and category-specific incidence ratesof syncope were computed. The survival rates among participantswith syncope due to specific causes were examined with Kaplan–Meiersurvival curves.32 Age- and multivariable-adjusted Cox proportional-hazardregression models33 were used to analyze the risk of each outcomeof interest among participants with cause-specific syncope (fouretiologic categories) as compared with participants withoutsyncope. We evaluated the outcomes of interest by using dummyvariables for each of the four etiologic categories. Multivariablemodels were adjusted for age, sex, presence or absence of ahistory of cardiovascular disease (myocardial infarction, coronaryheart disease, stroke or transient ischemic attack, congestiveheart failure, atrial fibrillation, and intermittent claudication),smoking status, presence or absence of hypertension, systolicblood pressure, presence or absence of diabetes, total cholesterollevel, heart rate, and use or nonuse of cardiac medication,including antihypertensive medications. Hypertension was a dichotomousvariable defined as a systolic blood pressure of at least 140mm Hg, a diastolic blood pressure of at least 90 mm Hg, or currentuse of antihypertensive medication. The presence or absenceof a history of cardiovascular disease, smoking status, presenceor absence of diabetes, use or nonuse of cardiac medication,and normal or elevated total cholesterol level (with an elevatedlevel defined as at least 200 mg per deciliter [5.2 mmol perliter]) were also included in the model as dichotomous variables.Age, systolic blood pressure, and heart rate were included ascontinuous variables.
Results
We followed 7814 participants (3563 men and 4251 women) foran average of 17.0 years (median, 19.1; interquartile range,10.6 to 23.6) during 133,164 person-years of follow-up. Theparticipants had a mean (±SD) age of 51.1±14.4years (range, 20 to 96). A total of 822 participants (348 menand 474 women; mean age, 65.8 years) reported syncope. Afterexcluding participants without follow-up (those whose firstepisode of syncope was reported at the last index examination),we included 727 participants in the outcome analysis.
Incidence
The overall incidence rate of a first report of syncope was6.2 per 1000 person-years. The incidence rates increased withage, with a sharp rise at 70 years (Figure 1). The age-adjustedincidence was 7.2 per 1000 person-years among both men and women.The age-adjusted incidence rate among participants with cardiovasculardisease was nearly twice that among participants without cardiovasculardisease (10.6 vs. 6.4 per 1000 person-years). The incidencerates of first reports of cardiac syncope, syncope of unknowncause, syncope due to stroke or transient ischemic attack, syncopedue to seizure, vasovagal syncope, orthostatic syncope, medication-inducedsyncope, and syncope of other causes were 0.59, 2.26, 0.26,0.30, 1.31, 0.58, 0.42, and 0.47 per 1000 person-years, respectively.Assuming a constant incidence rate over time, we calculateda 10-year cumulative incidence of syncope of 6 percent.
Figure 1. Incidence Rates of Syncope According to Age and Sex.
The incidence rates of syncope per 1000 person-years of follow-up increased with age among both men and women. The increase in the incidence rate was steeper starting at the age of 70 years. Syncope rates were similar among men and women.
Causes of Syncope
The distributions of causes in men and women, respectively,were as follows: cardiac causes (13.2 percent and 6.7 percent),unknown cause (31.0 percent and 40.7 percent), stroke or transientischemic attack (4.3 percent and 4.0 percent), seizure disorder(7.2 percent and 3.2 percent), vasovagal cause (19.8 percentand 22.2 percent), orthostatic cause (8.6 percent and 9.9 percent),medication (6.3 percent and 7.2 percent), and other causes (9.5percent and 6.1 percent). The causes of syncope according tocardiovascular disease status at base line are shown in Table 1.Overall, 56 percent of participants with a syncopal episodereported seeing a doctor or visiting a hospital for evaluation.
Table 1. Causes of Syncope According to Sex and the Presence or Absence of Cardiovascular Disease at Base Line.
Recurrence of Syncope
Five hundred seventy participants (78.4 percent) reported onlyone episode of syncope. One hundred fifty-seven participants(21.6 percent) reported one or more recurrences of syncope (17.6percent reported one recurrence, 3.3 percent two recurrences,and 0.7 percent three or more recurrences). The rate of recurrenceamong participants with a history of syncope was higher thanthe incidence of a first episode of syncope among those withoutsuch a history (multivariable-adjusted hazard ratio, 23.2; 95percent confidence interval, 14.2 to 37.9). The risk of recurrencewas especially high among participants with cardiac syncope(multivariable-adjusted hazard ratio, 30.0; 95 percent confidenceinterval, 14.9 to 60.3).
Follow-up
The characteristics of the 2181 study participants who wereeligible for follow-up are shown in Table 2. As compared withthose without syncope, participants with syncope of any cause,and in particular those with cardiac syncope, were more likelyto have a history of coronary artery disease or cerebrovasculardisease and to take cardiac or antihypertensive medications.During a mean follow-up of 8.6 years (median, 7.7), there were847 deaths from all causes, 263 myocardial infarctions or deathsfrom coronary heart disease, and 178 fatal or nonfatal strokes.
Figure 2. Overall Survival of Participants with Syncope, According to Cause, and Participants without Syncope.
P<0.001 for the comparison between participants with and those without syncope. The category "Vasovagal and other causes" includes vasovagal, orthostatic, medication-induced, and other, infrequent causes of syncope.
Table 3. Hazard Ratios for the Outcomes of Interest in Participants with Syncope as Compared with Participants without Syncope.
Secondary analyses were also performed to examine the relationsof cause-specific syncope to the outcomes of interest afterexclusion of data from 40 participants who had syncope due toseizures. The findings were similar to the results shown inTable 3, except that the association between neurologic syncopeand death from any cause was no longer statistically significant(hazard ratio, 1.24; 95 percent confidence interval, 0.81 to1.89).
Because cardiac syncope might have been preferentially diagnosedin participants with syncope who were already known to havecardiovascular disease, we also performed secondary analysesstratified according to the presence or absence of known cardiovasculardisease. The results were similar in the two groups (data notshown). In addition, to address the possibility that syncopeof unknown cause might have been associated with poor outcomesbecause persons with this diagnosis received a different levelof medical care, we performed analyses stratified accordingto whether the participant sought or did not seek medical carefor the syncopal event (130 and 131 participants, respectively).The data from 11 participants were excluded from this analysisbecause information on whether they sought medical care wasnot available. As compared with participants without syncope,participants with this diagnosis who sought medical care hada higher risk of death from any cause (multivariable-adjustedhazard ratio, 1.47; 95 percent confidence interval, 1.14 to1.90), although their risk of myocardial infarction or deathfrom coronary heart disease was not significantly elevated (adjustedhazard ratio, 1.07; 95 percent confidence interval, 0.63 to1.83). Participants with syncope of unknown cause who did notseek medical care had a higher risk of myocardial infarctionor death from coronary heart disease (adjusted hazard ratio,1.60; 95 percent confidence interval, 1.04 to 2.48), but theirrisk of death from any cause was not significantly elevated(adjusted hazard ratio, 1.23; 95 percent confidence interval,0.94 to 1.60).
Discussion
In this population-based study, we found a similar incidence of syncope in men and women.The incidence was almost doubledin participants with a history of cardiovascular disease. Mortalitywas about 30 percent higher among all participants with syncopeand among those with syncope of unknown cause than among thosewithout syncope; this increase was due largely to an increasedrisk of death from myocardial infarction or coronary heart disease.Cardiac syncope doubled the risk of death from any cause andincreased the risk of fatal and nonfatal cardiovascular events.Neurologic syncope was associated with an increased risk ofdeath from any cause and an increased risk of stroke.
Although the incidence of syncope rose sharply with advancingage, the age-specific annual incidence of syncope for thoseabove 80 years of age in our study (about 2 percent) was considerablylower than that reported by Lipsitz et al. (6 percent) in anelderly institutionalized population (mean age, 87 years).1Overall, 37 percent of syncopal events in our sample were due to unknown causes.The distribution of causes of syncope thatwe observed is similar to that reported elsewhere.34,35 Forexample, Linzer et al. reported that, on average, 34 percentof syncopal episodes could not be assigned to an etiologic categoryafter a standard evaluation with a detailed history taking,physical examination, and electrocardiography.36
Our findings are consistent with those of Kapoor15 in suggestingthat cardiac syncope is associated with increased risks of prematuredeath and cardiovascular events. Whether or not there was ahistory of cardiovascular disease, we found that participantswith a diagnosis of cardiac syncope were more likely to havea poor outcome than those without syncope.
Several other studies have evaluated the outcome of syncopeof unknown cause.18,19,20,21,22,23,24,25,26,27 The results suggestedthat among subjects with syncope that was initially classifiedas being of unknown cause and that was later found to have acardiac cause, the risk of death was higher than in the generalpopulation. Electrophysiological studies and electrocardiographicmonitoring in highly selected subgroups of patients37,38,39,40,41have suggested that 45 to 80 percent of cases of syncope classifiedas being of unknown cause could be assigned a cardiac cause.It is likely that many participants in our study with syncopeof unknown cause had unrecognized cardiac syncope, with itsattendant risk of an adverse outcome.
Participants with syncope of neurologic cause had more thantwice as high a risk of fatal or nonfatal stroke as subjectswithout syncope. The increased risk is probably attributableto a high risk of stroke, often recurrent, in participants withneurologic syncope who had preexisting cerebrovascular disease.
Among participants with syncope of identified cause, by farthe largest subgroup consisted of those with syncope of vasovagalor other causes, including orthostatic and medication-inducedsyncope. Among these participants we found no increase in therisk of death from any cause or in the risk of myocardial infarctionor death from coronary heart disease, in comparison to thosewithout syncope, even though the statistical power to detectsuch increases was high (96 percent power to detect a 50 percentincrease in the risk of death from any cause; 84 percent powerto detect a 75 percent increase in the risk of myocardial infarctionor death from coronary heart disease).
This study involved a population-based sample free of selectionbias and an extensive period of follow-up. However, some limitationsshould be noted. We attempted to minimize misclassificationof participants according to whether or not they had previouslyhad an episode of syncope by excluding those who had not undergonea clinical examination within four years before an examinationat which they reported syncope. However, a four-year intervalmay constitute a long recall period, especially for older patients.Differential recall bias is unlikely to have affected our findings,because our prospective cohort design ensured that exposureswere ascertained before the outcomes. Problems with recall,however, may have contributed to underestimation of the incidenceof syncope and hazard ratios for adverse outcomes associatedwith this diagnosis.42
Another concern is possible misclassification of participantsaccording to etiologic categories of syncope.43 Although wedid not develop explicit criteria for confirming a given causeof syncope, we sought to minimize misclassification by havingdiagnoses assigned by the consensus of two physician reviewers,unaware of the study outcomes, who reviewed all related outsiderecords and Framingham Heart Study examination records. Thepresence of other risk factors for cardiovascular disease orthe presence of cardiovascular disease may have contributedto cardiovascular risk among participants with syncope, butour findings persisted after we adjusted for these factors inmultivariable models and in secondary analyses stratified accordingto the presence or absence of known cardiovascular disease.Finally, our study sample consisted almost entirely of middle-agedand older white men and women, and thus the results may notbe generalizable to other populations.
Our findings suggest that persons with cardiac syncope constitutea high-risk group predisposed to morbidity and premature mortalityfrom cardiovascular disease who should be monitored closely.Persons with syncope of unknown cause appear to constitute amixed group at increased risk for death; this result suggeststhat further diagnostic testing may be warranted in these patients.The increased risk of stroke in participants with neurologicsyncope may be attributable to preexisting cerebrovascular disease.Our results also provide reassurance that vasovagal syncope has a benign prognosis.
Supported by grants (N01-HC-38038 and NS-17950) from the NationalHeart, Lung, and Blood Institute.
Source Information
From the National Heart, Lung, and Blood Institute Framingham Heart Study, Framingham, Mass. (E.S.S., J.C.E., M.G.L., M.H.C., L.C., E.J.B., D.L.); the Departments of Cardiology and Preventive Medicine, Boston Medical Center, Boston (E.J.B.); the National Heart, Lung, and Blood Institute, Bethesda, Md. (D.L.); and the Division of Cardiology, Beth Israel Deaconess Medical Center, Boston (D.L.).
Address reprint requests to Dr. Levy at the Framingham Heart Study, 73 Mt. Wayte Ave., Suite 2, Framingham, MA 01702-5827.
References
Lipsitz LA, Wei JY, Rowe JW. Syncope in an elderly, institutionalised population: prevalence, incidence, and associated risk. Q J Med 1985;55:45-54. [Abstract]
Savage DD, Corwin L, McGee DL, Kannel WB, Wolf PA. Epidemiologic features of isolated syncope: the Framingham Study. Stroke 1985;16:626-629. [Free Full Text]
Dermksian G, Lamb LE. Syncope in a population of healthy young adults: incidence, mechanisms, and significance. JAMA 1958;160:1200-1207.
Dermksian G, Lamb LE. Cardiac arrhythmias in experimental syncope. JAMA 1958;168:1623-1630.
Lamb LE, Green H, Combs JJ, Chessman SA, Hammond J. Incidence of loss of consciousness in 1,980 Air Force personnel. Aerosp Med 1960;31:973-988. [Medline]
Williams RL, Allen PD. Loss of consciousness: incidence, causes and electroencephalographic findings. Aerosp Med 1962;33:545-551. [Medline]
Murdoch BD. Loss of consciousness in healthy South African men: incidence, causes and relationship to EEG abnormality. S Afr Med J 1980;57:771-774. [Web of Science][Medline]
Kapoor WN, Karpf M, Wieand S, Peterson JR, Levey GS. A prospective evaluation and follow-up of patients with syncope. N Engl J Med 1983;309:197-204. [Abstract]
Day SC, Cook EF, Funkenstein H, Goldman L. Evaluation and outcome of emergency room patients with transient loss of consciousness. Am J Med 1982;73:15-23. [CrossRef][Web of Science][Medline]
Eagle KA, Black HR, Cook EF, Goldman L. Evaluation of prognostic classifications for patients with syncope. Am J Med 1985;79:455-460. [CrossRef][Web of Science][Medline]
Lee RT, Cook EF, Day SC, Goldman L. Long-term survival after transient loss of consciousness. J Gen Intern Med 1988;3:337-343. [Web of Science][Medline]
Martin TP, Hanusa BH, Kapoor WN. Risk stratification of patients with syncope. Ann Emerg Med 1997;29:459-466. [CrossRef][Web of Science][Medline]
Silverstein MD, Singer DE, Mulley AG, Thibault GE, Barnett GO. Patients with syncope admitted to medical intensive care units. JAMA 1982;248:1185-1189. [Free Full Text]
Houdent C, Morcamp D, Séréni D, et al. Pronostic à un an des lipothymies et pertes de connaissance brèves après 65 ans: etude multicentrique de 188 cas. Presse Med 1988;17:626-629. [Medline]
Kapoor WN. Evaluation and outcome of patients with syncope. Medicine (Baltimore) 1990;69:160-175. [Medline]
Kapoor WN, Hanusa BH. Is syncope a risk factor for poor outcomes? Comparison of patients with and without syncope. Am J Med 1966;100:646-655.
Getchell WS, Larsen GC, Morris CD, McAnulty JH. Epidemiology of syncope in hospitalized patients. J Gen Intern Med 1999;14:677-687. [CrossRef][Web of Science][Medline]
Morady F, Shen E, Schwartz A, et al. Long-term follow-up of patients with recurrent unexplained syncope evaluated by electrophysiologic testing. J Am Coll Cardiol 1983;2:1053-1059. [Abstract]
Doherty JU, Pembrook-Rogers D, Grogan EW, et al. Electrophysiologic evaluation and follow-up characteristics of patients with recurrent unexplained syncope and presyncope. Am J Cardiol 1985;55:703-708. [CrossRef][Web of Science][Medline]
Olshansky B, Mazuz M, Martins JB. Significance of inducible tachycardia in patients with syncope of unknown origin: a long-term follow-up. J Am Coll Cardiol 1985;5:216-223. [Abstract]
Kapoor WN, Cha R, Peterson JR, Wieand HS, Karpf M. Prolonged electrocardiographic monitoring in patients with syncope: importance of frequent or repetitive ventricular ectopy. Am J Med 1987;82:20-28. [Medline]
Krol RB, Morady F, Flaker GC, et al. Electrophysiologic testing in patients with unexplained syncope: clinical and noninvasive predictors of outcome. J Am Coll Cardiol 1987;10:358-363. [Abstract]
Bass EB, Elson JJ, Fogoros RN, Peterson J, Arena VC, Kapoor WM. Long-term prognosis of patients undergoing electrophysiologic studies for syncope of unknown origin. Am J Cardiol 1988;62:1186-1191. [CrossRef][Web of Science][Medline]
Kushner JA, Kou WH, Kadish AH, Morady F. Natural history of patients with unexplained syncope and a nondiagnostic electrophysiologic study. J Am Coll Cardiol 1989;14:391-396. [Abstract]
Sra JS, Anderson AJ, Sheikh SH, et al. Unexplained syncope evaluated by electrophysiologic studies and head-up tilt testing. Ann Intern Med 1991;114:1013-1019. [Web of Science][Medline]
Gouëllo JP, Victor J, Dupuis JM, Tadeí A. Exploration électrophysiologique pour le diagnostic et le pronostic des syncopes de cause indéterminée. Presse Med 1995;24:387-392. [Medline]
Olshansky B, Hahn EA, Hartz VL, Prater SP, Mason JW. Clinical significance of syncope in the Electrophysiologic Study versus Electrocardiographic Monitoring (ESVEM) trial. Am Heart J 1999;137:878-886. [CrossRef][Web of Science][Medline]
Dawber TR, Meadors GF, Moore FE Jr. Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health 1951;41:279-286. [Free Full Text]
Kannel WB, Feinleib M, McNamara PM, Garrison RJ, Castelli WP. An investigation of coronary heart disease in families: the Framingham Offspring Study. Am J Epidemiol 1979;110:281-290. [Free Full Text]
Kannel WB, Wolf PA, Garrison RJ. Framingham Heart Study, section 34: some risk factors related to the annual incidence of cardiovascular disease and death in pooled repeated biennial measurements: 30 year follow-up. Bethesda, Md.: National Institutes of Health, 1987. (NIH publication no. 87-2703.)
SAS/STAT software: changes and enhancements through release 6.12. Cary, N.C.: SAS Institute, 1997:413-20, 873-948.
Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
Cox DR. Regression models and life-tables. J R Stat Soc [B] 1972;34:187-220.
Martin GJ, Adams SL, Martin HG, Mathews J, Zull D, Scanlon PJ. Prospective evaluation of syncope. Ann Emerg Med 1984;13:499-504. [CrossRef][Web of Science][Medline]
Kapoor WN. Workup and management of patients with syncope. Med Clin North Am 1995;79:1153-1170. [Web of Science][Medline]
Linzer M, Yang EH, Estes NA III, Wang P, Vorperian VR, Kapoor WN. Diagnosing syncope. Part 1. Value of history, physical examination, and electrocardiography: Clinical Efficacy Assessment Project of the American College of Physicians. Ann Intern Med 1997;126:989-996. [Free Full Text]
Hess DS, Morady F, Scheinman MM. Electrophysiologic testing in the evaluation of patients with syncope of undetermined origin. Am J Cardiol 1982;50:1309-1315. [CrossRef][Web of Science][Medline]
Teichman SL, Felder SD, Matos JA, Kim SG, Waspe LE, Fisher JD. The value of electrophysiologic studies in syncope of undetermined origin: report of 150 cases. Am Heart J 1985;110:469-479. [CrossRef][Web of Science][Medline]
Linzer M, Pritchett EL, Pontinen M, McCarthy E, Divine GW. Incremental diagnostic yield of loop electrocardiographic recorders in unexplained syncope. Am J Cardiol 1990;66:214-219. [CrossRef][Web of Science][Medline]
Moazez F, Peter T, Simonson J, Mandel WJ, Vaughn C, Gang E. Syncope of unknown origin: clinical, noninvasive, and electrophysiologic determinants of arrhythmia induction and symptom recurrence during long-term follow-up. Am Heart J 1991;121:81-88. [CrossRef][Web of Science][Medline]
Linzer M, Yang EH, Estes NA III, Wang P, Vorperian VR, Kapoor WN. Diagnosing syncope. Part 2. Unexplained syncope: Clinical Efficacy Assessment Project of the American College of Physicians. Ann Intern Med 1997;127:76-86. [Free Full Text]
Barry D. Differential recall bias and spurious associations in case/control studies. Stat Med 1996;15:2603-2616. [CrossRef][Medline]
Dosemeci M, Wacholder S, Lubin JH. Does nondifferential misclassification of exposure always bias a true effect toward the null value? Am J Epidemiol 1990;132:746-748. [Free Full Text]
Developed in collaboration with, , European Heart Rhythm Association (EHRA), , Heart Failure Association (HFA), , and Heart Rhythm Society (HRS), , Endorsed by the following societies, , European Society of Emergency Medicine (EuSEM), , European Federation of Internal Medicine (EFIM), , European Union Geriatric Medicine Society (EUGMS), , American Geriatrics Society (AGS), , European Neurological Society (ENS), , European Federation of Autonomic Societies (EFAS), , American Autonomic Society (AAS), , Authors/Task Force Members, , Moya, A., Sutton, R., Ammirati, F., Blanc, J.-J., Brignole, M., Dahm, J. B., Deharo, J.-C., Gajek, J., Gjesdal, K., Krahn, A., Massin, M., Pepi, M., Pezawas, T., Granell, R. R., Sarasin, F., Ungar, A., van Dijk, J. G., Walma, E. P., Wieling, W., External Contributors, , Abe, H., Benditt, D. G., Decker, W. W., Grubb, B. P., Kaufmann, H., Morillo, C., Olshansky, B., Parry, S. W., Sheldon, R., Shen, W. K., ESC Committee for Practice Guidelines (CPG), , Vahanian, A., Auricchio, A., Bax, J., Ceconi, C., Dean, V., Filippatos, G., Funck-Brentano, C., Hobbs, R., Kearney, P., McDonagh, T., McGregor, K., Popescu, B. A., Reiner, Z., Sechtem, U., Sirnes, P. A., Tendera, M., Vardas, P., Widimsky, P., Document Reviewers, , Auricchio, A., Acarturk, E., Andreotti, F., Asteggiano, R., Bauersfeld, U., Bellou, A., Benetos, A., Brandt, J., Chung, M. K., Cortelli, P., Da Costa, A., Extramiana, F., Ferro, J., Gorenek, B., Hedman, A., Hirsch, R., Kaliska, G., Kenny, R. A., Kjeldsen, K. P., Lampert, R., Molgard, H., Paju, R., Puodziukynas, A., Raviele, A., Roman, P., Scherer, M., Schondorf, R., Sicari, R., Vanbrabant, P., Wolpert, C., Zamorano, J. L.
(2009). Guidelines for the diagnosis and management of syncope (version 2009): The Task Force for the Diagnosis and Management of Syncope of the European Society of Cardiology (ESC). Eur Heart J
30: 2631-2671
[Full Text]
Turley, A. J., Tynan, M. M., Plummer, C. J.
(2009). Time to manual activation of implantable loop recorders--implications for programming recording period: a 10-year single-centre experience. Europace
11: 1359-1361
[Abstract][Full Text]
Sorajja, D., Nesbitt, G. C., Hodge, D. O., Low, P. A., Hammill, S. C., Gersh, B. J., Shen, W.-K.
(2009). Syncope While Driving: Clinical Characteristics, Causes, and Prognosis. Circulation
120: 928-934
[Abstract][Full Text]
Benditt, D. G., Nguyen, J. T.
(2009). Syncope: therapeutic approaches.. J Am Coll Cardiol
53: 1741-1751
[Abstract][Full Text]
Stockley, C J, Bonney, M E, Gray, A J, Reed, M J
(2009). Syncope management in the UK and Republic of Ireland. Emerg. Med. J.
26: 331-333
[Abstract][Full Text]
Task Force members, , Brignole, M., Vardas, P., Hoffman, E., Huikuri, H., Moya, A., Ricci, R., Sulke, N., Wieling, W., EHRA Scientific Documents Committee, , Auricchio, A., Lip, G. Y.H., Almendral, J., Kirchhof, P., Aliot, E., Gasparini, M., Braunschweig, F., Document Reviewers, , Lip, G. Y.H., Almendral, J., Kirchhof, P., Botto, G. L.
(2009). Indications for the use of diagnostic implantable and external ECG loop recorders. Europace
11: 671-687
[Full Text]
Spirito, P., Autore, C., Rapezzi, C., Bernabo, P., Badagliacca, R., Maron, M. S., Bongioanni, S., Coccolo, F., Estes, N.A. M., Barilla, C. S., Biagini, E., Quarta, G., Conte, M. R., Bruzzi, P., Maron, B. J.
(2009). Syncope and Risk of Sudden Death in Hypertrophic Cardiomyopathy. Circulation
119: 1703-1710
[Abstract][Full Text]
Brignole, M., Blanc, J.-J., Sutton, R., Moya, A.
(2009). CHAPTER 26 Syncope. ESC Textbook of Cardiovascular Medicine
2: med-9780199566990-chapter-med-9780199566990-chapter
[Abstract][Full Text]
Del Rosso, A, Ungar, A, Maggi, R, Giada, F, Petix, N R, De Santo, T, Menozzi, C, Brignole, M
(2008). Clinical predictors of cardiac syncope at initial evaluation in patients referred urgently to a general hospital: the EGSYS score. Heart
94: 1620-1626
[Abstract][Full Text]
Romero-Ortuno, R., Kenny, R. A.
(2008). Is it cardiac? Assessment of syncope with a scoring system. Heart
94: 1528-1529
[Full Text]
Chen, L. Y., Benditt, D. G., Shen, W.-K.
(2008). Management of Syncope in Adults: An Update. Mayo Clin Proc.
83: 1280-1293
[Abstract][Full Text]
Haissaguerre, M., Derval, N., Sacher, F., Jesel, L., Deisenhofer, I., de Roy, L., Pasquie, J.-L., Nogami, A., Babuty, D., Yli-Mayry, S., De Chillou, C., Scanu, P., Mabo, P., Matsuo, S., Probst, V., Le Scouarnec, S., Defaye, P., Schlaepfer, J., Rostock, T., Lacroix, D., Lamaison, D., Lavergne, T., Aizawa, Y., Englund, A., Anselme, F., O'Neill, M., Hocini, M., Lim, K. T., Knecht, S., Veenhuyzen, G. D., Bordachar, P., Chauvin, M., Jais, P., Coureau, G., Chene, G., Klein, G. J., Clementy, J.
(2008). Sudden Cardiac Arrest Associated with Early Repolarization. NEJM
358: 2016-2023
[Abstract][Full Text]
Bos, M. J., Koudstaal, P. J., Breteler, M. M. B.
(2008). Prognosis of Transient Neurological Attacks--Reply. JAMA
299: 1772-1773
[Full Text]
van Dijk, J. G., Thijs, R. D., Wieling, W.
(2008). Prognosis of Transient Neurological Attacks. JAMA
299: 1771-1772
[Full Text]
Olshansky, B., Poole, J. E., Johnson, G., Anderson, J., Hellkamp, A. S., Packer, D., Mark, D. B., Lee, K. L., Bardy, G. H., for the SCD-HeFT Investigators,
(2008). Syncope Predicts the Outcome of Cardiomyopathy Patients: Analysis of the SCD-HeFT Study. J Am Coll Cardiol
51: 1277-1282
[Abstract][Full Text]
Pierre, B., Fauchier, L., Breard, G., Marie, O., Poret, P., Babuty, D.
(2008). Implantable loop recorder for recurrent syncope: influence of cardiac conduction abnormalities showing up on resting electrocardiogram and of underlying cardiac disease on follow-up developments. Europace
10: 477-481
[Abstract][Full Text]
Ammirati, F., Colaceci, R., Cesario, A., Strano, S., Della Scala, A., Colangelo, I., De Santo, T., Toscano, E., Ricci, R., Santini, M.
(2008). Management of syncope: clinical and economic impact of a Syncope Unit. Europace
10: 471-476
[Abstract][Full Text]
Auer, J.
(2008). Syncope and trauma. Are syncope-related traumatic injuries the key to find the specific cause of the symptom?. Eur Heart J
29: 576-578
[Full Text]
Tan, M. P., Parry, S. W.
(2008). Vasovagal syncope in the older patient.. J Am Coll Cardiol
51: 599-606
[Abstract][Full Text]
Ross, R., Parry, S., Norton, M., Newton, J.L.
(2008). Self-reported symptom burden; outcome in 418 patients from the Newcastle Vasovagal (Neurocardiogenic) cohort. QJM
101: 127-135
[Abstract][Full Text]
Costantino, G., Perego, F., Dipaola, F., Borella, M., Galli, A., Cantoni, G., Dell'Orto, S., Dassi, S., Filardo, N., Duca, P. G., Montano, N., Furlan, R., on behalf of the STePS Investigators,
(2008). Short- and Long-Term Prognosis of Syncope, Risk Factors, and Role of Hospital Admission: Results From the STePS (Short-Term Prognosis of Syncope) Study. J Am Coll Cardiol
51: 276-283
[Abstract][Full Text]
Kuhne, M., Schaer, B., Moulay, N., Sticherling, C., Osswald, S.
(2007). Holter monitoring for syncope: diagnostic yield in different patient groups and impact on device implantation. QJM
100: 771-777
[Abstract][Full Text]
Reed, M. J, Newby, D. E, Coull, A. J, Jacques, K. G, Prescott, R. J, Gray, A. J
(2007). Role of brain natriuretic peptide (BNP) in risk stratification of adult syncope. Emerg. Med. J.
24: 769-773
[Abstract][Full Text]
Bordier, P., Colsy, M., Robert, F., Bourenane, G.
(2007). Prevalence of positive carotid sinus massage and related risk of syncope in patients with Alzheimer's disease. Europace
9: 829-834
[Abstract][Full Text]
Marquez, M.F., Hernandez-Pacheco, G., Hermosillo, A. G., Gomez, J. R., Cardenas, M., Vargas-Alarcon, G.
(2007). The Arg389Gly {beta}1-adrenergic receptor gene polymorphism and susceptibility to faint during head-up tilt test. Europace
9: 585-588
[Abstract][Full Text]
Sud, S., Klein, G. J., Skanes, A. C., Gula, L. J., Yee, R., Krahn, A. D.
(2007). Implications of mechanism of bradycardia on response to pacing in patients with unexplained syncope. Europace
9: 312-318
[Abstract][Full Text]
Reed, M. J, Newby, D. E, Coull, A. J, Jacques, K. G, Prescott, R. J, Gray, A. J
(2007). The Risk stratification Of Syncope in the Emergency department (ROSE) pilot study: a comparison of existing syncope guidelines. Emerg. Med. J.
24: 270-275
[Abstract][Full Text]
Benditt, D. G., Olshansky, B., Wieling, W., on behalf of the Ad Hoc Syncope Consortium,
(2006). The ACCF/AHA Scientific Statement on Syncope Needs Rethinking. J Am Coll Cardiol
48: 2598-2599
[Full Text]
Benditt, D. G., on behalf of the Ad Hoc Syncope Consortium,
(2006). The ACCF/AHA Scientific Statement on Syncope: a document in need of thoughtful revision. Europace
8: 1017-1021
[Abstract][Full Text]
Petkar, S., Cooper, P., Fitzpatrick, A. P
(2006). How to avoid a misdiagnosis in patients presenting with transient loss of consciousness.. Postgrad. Med. J.
82: 630-641
[Abstract][Full Text]
Serletis, A., Rose, S., Sheldon, A. G., Sheldon, R. S.
(2006). Vasovagal syncope in medical students and their first-degree relatives. Eur Heart J
27: 1965-1970
[Abstract][Full Text]
Reed, M J, Gray, A
(2006). Collapse query cause: the management of adult syncope in the emergency department.. Emerg. Med. J.
23: 589-594
[Abstract][Full Text]
Fitzpatrick, A. P, Cooper, P.
(2006). Diagnosis and management of patients with blackouts.. Heart
92: 559-568
[Full Text]
Guzman, J. C., Garcia, R. G., Dillenburg, R., Sieger, F. S., Lopez-Jaramillo, P., Morillo, C. A.
(2006). Central serotoninergic response to orthostatic challenge in patients with neurocardiogenic syncope.. Europace
8: 306-311
[Abstract][Full Text]
Enseleit, F., Duru, F.
(2006). Long-term continuous external electrocardiographic recording: a review.. Europace
8: 255-266
[Abstract][Full Text]
Yiu, D., Gieroba, Z., Hall, K., Mackintosh, S., Russell, A., Mangoni, A. A.
(2006). An early drop in systolic blood pressure predicts a positive tilt table test in elderly patients with unexplained falls or syncope. Age Ageing
35: 183-185
[Full Text]
Morillo, C. A.
(2006). Evidence-based common sense: the role of clinical history for the diagnosis of vasovagal syncope. Eur Heart J
27: 253-254
[Full Text]
Baron-Esquivias, G., Moreno, S. G., Martinez, A., Pedrote, A., Vazquez, F., Granados, C., Bollain, E., Lage, E., de la Llera, L. D., Rodriguez, M. J., Errazquin, F., Burgos, J.
(2006). Cost of diagnosis and treatment of syncope in patients admitted to a cardiology unit. Europace
8: 122-127
[Abstract][Full Text]
Brignole, M., Menozzi, C., Bartoletti, A., Giada, F., Lagi, A., Ungar, A., Ponassi, I., Mussi, C., Maggi, R., Re, G., Furlan, R., Rovelli, G., Ponzi, P., Scivales, A., for the Evaluation of Guidelines in Syncope Study,
(2006). A new management of syncope: prospective systematic guideline-based evaluation of patients referred urgently to general hospitals. Eur Heart J
27: 76-82
[Abstract][Full Text]
Grossman, S. A., Shapiro, N. I., Van Epp, S., Kohen, R., Arnold, R., Moore, R., Lee, L., Wolfe, R. E., Lipsitz, L. A.
(2005). Sex Differences in the Emergency Department Evaluation of Elderly Patients With Syncope. Journals of Gerontology Series A: Biological Sciences and Medical Sciences
60: 1202-1205
[Abstract][Full Text]
Binder, W. D., Fifer, M. A., King, M. E., Stone, J. R.
(2005). Case 26-2005 - A 48-Year-Old Man with Sudden Loss of Consciousness while Jogging. NEJM
353: 824-832
[Full Text]
Schnipper, J. L., Ackerman, R. H., Krier, J. B., Honour, M.
(2005). Diagnostic Yield and Utility of Neurovascular Ultrasonography in the Evaluation of Patients With Syncope. Mayo Clin Proc.
80: 480-488
[Abstract]
van Dijk, J. G.
(2005). Explaining syncope: Faints need not confuse. Europace
7: 392-395
[Full Text]
Maisel, W. H.
(2004). Specialized Syncope Evaluation. Circulation
110: 3621-3623
[Full Text]
Shen, W. K., Decker, W. W., Smars, P. A., Goyal, D. G., Walker, A. E., Hodge, D. O., Trusty, J. M., Brekke, K. M., Jahangir, A., Brady, P. A., Munger, T. M., Gersh, B. J., Hammill, S. C., Frye, R. L.
(2004). Syncope Evaluation in the Emergency Department Study (SEEDS): A Multidisciplinary Approach to Syncope Management. Circulation
110: 3636-3645
[Abstract][Full Text]
Colivicchi, F., Ammirati, F., Santini, M.
(2004). Epidemiology and prognostic implications of syncope in young competing athletes. Eur Heart J
25: 1749-1753
[Abstract][Full Text]
Samii, S., Khan, M. H., MacLean, D. A., King, N., Herr, M. D., Sinoway, L. I.
(2004). Muscle Interstitial Calcium During Head-Up Tilt in Humans. Circulation
109: 215-219
[Abstract][Full Text]
(2004). Guidelines on Management (diagnosis and treatment) of syncope - update 2004: The Task Force on Syncope, European Society of Cardiology. Europace
6: 467-537
[Full Text]
Farwell, D J, Sulke, A N
(2004). Does the use of a syncope diagnostic protocol improve the investigation and management of syncope?. Heart
90: 52-58
[Abstract][Full Text]
Kolias, T. J
(2003). Echocardiography was useful in evaluating unexplained syncope. Evid. Based Med.
8: 96-96
[Full Text]
(2003). OTHER ARTICLES NOTED (Nov 01 to 18 Oct 02). Evid. Based Nurs.
6: e1-1
[Full Text]
t,
Previous
